Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis.

Shiue AB, Stancoven AB, Purcell JB, Pinkston K, Wang A, Khera A, de Lemos JA, Peterson GE.

Am J Cardiol. 2010 Oct 1;106(7):1011-5. doi: 10.1016/j.amjcard.2010.05.034.

PMID:
20854966
2.
3.

Relation of troponin elevation to outcome in patients with infective endocarditis.

Purcell JB, Patel M, Khera A, de Lemos JA, Forbess LW, Baker S, Cabell CH, Peterson GE.

Am J Cardiol. 2008 May 15;101(10):1479-81. doi: 10.1016/j.amjcard.2008.01.031.

PMID:
18471461
4.

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Gibson CM, Cannon CP, Braunwald E.

J Am Coll Cardiol. 2003 Apr 16;41(8):1264-72. Erratum in: J Am Coll Cardiol. 2003 May 21;41(10):1852.

5.

B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.

Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E.

J Am Coll Cardiol. 2004 Jul 21;44(2):335-9.

7.

Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department.

Christ M, Laule K, Klima T, Hochholzer W, Breidthardt T, Perruchoud AP, Mueller C.

Int J Cardiol. 2008 May 7;126(1):73-8.

PMID:
17481748
9.

The inability of B-type natriuretic protein to predict short-term risk of death or myocardial infarction in non-heart-failure patients with marginally increased troponin levels.

Hubbard BL, Newton CR, Carter PM, Fowler JJ, Schaldenbrand J, Singal B, Cowen ME.

Ann Emerg Med. 2010 Nov;56(5):472-80. doi: 10.1016/j.annemergmed.2010.03.005.

PMID:
20363529
10.

A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.

Bolliger D, Seeberger MD, Lurati Buse GA, Christen P, Rupinski B, Gürke L, Filipovic M.

Anesth Analg. 2009 Apr;108(4):1069-75. doi: 10.1213/ane.0b013e318194f3e6.

PMID:
19299763
11.

Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes.

Kuwabara Y, Sato Y, Miyamoto T, Taniguchi R, Matsuoka T, Isoda K, Yamane K, Nishi K, Fujiwara H, Takatsu Y.

Circ J. 2007 Jul;71(7):1047-51.

12.

Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality.

Provenchère S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Bénessiano J.

Crit Care Med. 2006 Apr;34(4):995-1000.

PMID:
16484891
13.

Association of troponin T, detected with highly sensitive assay, and outcomes in infective endocarditis.

Stancoven AB, Shiue AB, Khera A, Pinkston K, Hashim IA, Wang A, de Lemos JA, Peterson GE.

Am J Cardiol. 2011 Aug 1;108(3):416-20. doi: 10.1016/j.amjcard.2011.03.061.

PMID:
21600535
14.

Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis.

Ishii J, Nomura M, Okuma T, Minagawa T, Naruse H, Mori Y, Ishikawa T, Kurokawa H, Hirano T, Kondo T, Nagamura Y, Ezaki K, Hishida H.

Clin Chim Acta. 2001 Oct;312(1-2):69-79.

PMID:
11580911
15.

Combined measurements of cardiac troponin I and brain natriuretic peptide are useful for predicting adverse outcomes in hypertrophic cardiomyopathy.

Kubo T, Kitaoka H, Okawa M, Yamanaka S, Hirota T, Baba Y, Hayato K, Yamasaki N, Matsumura Y, Yasuda N, Sugiura T, Doi YL.

Circ J. 2011;75(4):919-26.

16.

Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.

Fonarow GC, Peacock WF, Horwich TB, Phillips CO, Givertz MM, Lopatin M, Wynne J; ADHERE Scientific Advisory Committee and Investigators..

Am J Cardiol. 2008 Jan 15;101(2):231-7. doi: 10.1016/j.amjcard.2007.07.066.

PMID:
18178412
17.

Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.

Boffa GM, Zaninotto M, Bacchiega E, Nalli C, Forni M, Tiso E, Cacciavillani L, Razzolini R, Plebani M.

Ital Heart J. 2005 Feb;6(2):125-32.

PMID:
15819505
18.

Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.

Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.

Indian Heart J. 2008 Nov-Dec;60(6):536-42.

PMID:
19276492
19.

Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies.

Miller WL, Hartman KA, Burritt MF, Burnett JC Jr, Jaffe AS.

Clin Cardiol. 2007 May;30(5):245-50.

20.
Items per page

Supplemental Content

Support Center